Current Study: C 01

Study: C 01

Investigator: Thomas Marbury, MD
Category:
Research Study: Liver Studies
PURPOSE:
• To determine how the investigational drug is broken down and removed from the body in volunteers with various degrees of liver impairment when compared to volunteers with normal liver function
• Information regarding safety and side effects that may occur will also be collected
• This study is for research purposes only and is not intended to treat your liver disease
METHOD OF ADMINISTRATION:
Single oral dose of study medication

KEY REQUIREMENTS TO QUALIFY FOR THIS STUDY:

• 18 to 75 years old
• Diagnosed with liver disease or liver damage
• May have cirrhosis due to Hepatitis B or C, fatty liver disease, including NASH, or history of alcohol-related liver disease
• May be taking medicines such as spironolactone, furosemide, lactulose, or Xifaxan®
• May have fluid in your abdomen or previous encephalopathy (brain condition that causes irritability, sleepiness, or trouble sleeping)

LENGTH/DURATION:
• 5 days and 4 nights in our research facility
• 6 outpatient follow-up visits
LOCATION:
5055 South Orange Avenue, Orlando, FL 32809
COMPENSATION:
Qualified participants will receive study medication, study related physical exams and laboratory tests
Qualified study participants will be compensated up to $1,925 for time and travel
WHOM TO CONTACT:
Recruitment Department: 407-240-7876

Orlando Clinical Research Center
5055 South Orange Avenue
Orlando, FL 32809

Recruiting Number: 407.240.7878

Apply now for Study: C 01

Close